Deciphex

The Patholytix Data Capture Module is a game-changer for non-clinical study reviews, enabling users to review and score studies on a single platform for the first time. Its dynamic workflows for glass, digital, and hybrid studies, real-time data sync capabilities, geolocated findings, and flexible scoring templates accelerate critical decisions in drug safety assessment. Watch our webinar on-demand to find out more:  https://lnkd.in/eX7bnUUY #digitalpathology #drugdiscovery #pathologyreviews #datamanagement #drugdevelopment #GLP #nonGLP #datacapture #Webinar #PatholytixDCM

🌟 Exciting News!🌟 Diagnexia Receives CAP Accreditation! We are thrilled to announce that Diagnexia has received accreditation from the College of American Pathologists (CAP) for their Naperville/US facility, following a rigorous on-site inspection. This prestigious recognition underscores their commitment to providing the highest quality pathology services. This CAP accreditation reflects the hard work and dedication of the entire team, ensuring they meet the highest standards in laboratory medicine. With CAP's rigorous standards and extensive proficiency testing programs, they are committed to delivering exceptional diagnostic services worldwide, with best-in-class solutions designed to drive operational excellence and ensure the best patient care. Read more here: https://lnkd.in/ejANMwWs #Diagnexia #CAPAccreditation #DigitalPathology

🌍 Access Your Research Data Anytime, Anywhere! 🌍 With Deciphex’s global network of scanning centres, digitisation services are on your doorstep. Our centres across the US, Canada, UK, Switzerland, and upcoming locations in Japan and Continental Europe ensure that your slides are scanned and uploaded to our secure Patholytix Cloud, making your research data easily accessible and shareable with partners. Once digitized, your physical slides are promptly returned to you. 📍 Multiple global scanning locations. 🔒 Secure and redundant data storage. 🌐 Convenient access to your research library via Patholytix. Unlock the power of global accessibility for your research: https://lnkd.in/epV72hAm #GlobalAccessibility #ScanningServices #Pathology #ResearchAnywhere #SecureData

Novartis is making significant strides with AI to revolutionise drug discovery and development. Their focus on using AI to understand diseases, identify drug targets, and improve research efficiency is impressive. We're delighted to be part of this transformative journey, collaborating with Novartis to leverage AI for better detection and measurement of tissue lesions, ultimately accelerating the drug development process. Read the full article to learn more about our collaboration: https://lnkd.in/ey5SBCYp #AI #Pharmaceuticals #DrugDiscovery #Deciphex #Innovation #Healthcare

We had a wonderful time at the Japanese Society of Toxicology conference in beautiful Fukuoka, Japan! Although the conference ends today, there's still time to visit us at booth #114 on the 5th floor. This is a fantastic opportunity to connect with our specialists and management team. Whether you have questions, need insights, or want to discuss potential collaborations, we’re here to engage and share our expertise in digital pathology. Don’t miss out on this chance to meet face-to-face and explore the latest advancements in the field! We look forward to seeing you there!

🌟 We're thrilled to announce that Deciphex has been honoured with not one, but two prestigious awards at the Life Science Industry Awards. 🌟 🏆 Product Impact Award 🏆 Innovation of the Year These recognitions underscore our unwavering commitment to innovation and excellence in the life sciences sector. We are immensely proud of our team's hard work and dedication, which made these achievements possible. Thank you to the Life Sciences Industry Awards for these incredible honours. #LifeSciencesIndustryAwards #Pathology #DigitalPathology

Patholytix are thrilled to announce our participation in the Japanese Society of Toxicology conference from July 3rd to 5th in beautiful Fukuoka, Japan! 🇯🇵 This is a fantastic opportunity to connect with our specialists and management team. Whether you have questions, need insights, or want to discuss potential collaborations, we’re here to engage and share our expertise in toxicology. Don’t miss out on this chance to meet face-to-face and explore the latest advancements in the field! Looking forward to seeing you there!

Digital pathology for tox path? For those > 1k slide studies? Heck yeah! ...today at STP... It was one of the few days of the year when I could show others how we do digital pathology at Charles River Laboratories. Our partner in this endeavor is Deciphex, and their team had computers loaded with mockup studies to show exactly how an AI-powered tox path study reading workflow looks. So I "indulged" in the pleasure of explaining to everyone who was passing by: - how this system works, - how it makes my tox path life easier - and how they need to start using it so that their tox path lives can become easier too! (Seriously - Thank you so much for putting up with me and for not showing the slightest sign of annoyance:) I took advantage of this situation because next time, when it becomes mainstream there might not be anyone who needs this explanation anymore. #toxpath #imageanalysis #AIindrugdevelopment #stp2024

🎉 Today is the day! We are delighted to be at STP in Baltimore and ready to showcase our new Foresight AI service. Join our team of experts: Colin Doolan, Andrew Fink, Gary Roche, Laoise Lord Bissett, and David A. Moser. Don’t miss Laoise presenting our exciting poster at P35 and P36, "Development of AI classifiers and integration into a commercially available decision support tool for toxicologic pathology." Discover how Foresight AI, developed with Charles River Laboratories, can revolutionize pathologic assessments with advanced AI classifiers for identifying common rat non-neoplastic lesions. 📍 Swing by booth 111 to experience Foresight AI firsthand! Excited to connect with you all! 🌐 #STP2024

"JumpCloud’s platform simply makes everything work.” Pathology software company Deciphex has deployed JumpCloud to help achieve both regulatory compliance and robust security for 250 employee devices – part of a larger effort to simplify IT management and increase security. “JumpCloud’s platform offers complete peace of mind. It provides flexibility and maturity to pick and choose the tools that we need. And it does so as our requirements evolve," explained Ben Cranks, application support specialist at Deciphex. See how Deciphex will use JumpCloud for SSO to ensure only authorized users can access the correct resources and MDM to manage user access and automate the employee lifecycle: https://lnkd.in/gQ5CP7k8